Related Experiment Video
Updated: Mar 21, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma
1National Brain Research Centre, Department of Molecular and Cellular Neuroscience Division, Manesar, Gurgaon, Haryana 122051, India.
Abstract:
Given the involvement of telomerase activation and dysregulated metabolism in glioma progression, the connection between these two critical players was investigated. Pharmacological inhibition of human Telomerase reverse transcriptase (hTERT) by Costunolide induced glioma cell apoptosis in a reactive oxygen species (ROS)-dependent manner. Costunolide induced an ROS-dependent increase in p53 abrogated telomerase activity. Costunolide decreased Nrf2 level; and ectopic Nrf2 expression decreased Costunolide-induced ROS generation. While TERT knock-down abrogated Nrf2 levels, overexpression of Nrf2 increased TERT expression. Inhibition of hTERT either by Costunolide, or by siRNA or dominant-negative hTERT (DN-hTERT) abrogated (i) expression of Glucose-6-phosphate dehydrogenase (G6PD) and Transketolase (TKT) - two major nodes in the pentose phosphate (PPP) pathway; and (ii) phosphorylation of glycogen synthase (GS). hTERT knock-down decreased TKT activity and increased glycogen accumulation. Interestingly, siRNA-mediated knock-down of TKT elevated glycogen accumulation. Coherent with the in vitro findings, Costunolide reduced tumor burden in heterotypic xenograft glioma mouse model. Costunolide-treated tumors exhibited diminished TKT activity, heightened glycogen accumulation, and increased senescence. Importantly, glioblastoma multiforme (GBM) patient tumors bearing TERT promoter mutations (C228T and C250T) known to be associated with increased telomerase activity; exhibited elevated Nrf2 and TKT expression and decreased glycogen accumulation. Taken together, our findings highlight the previously unknown (i) role of telomerase in the regulation of PPP and glycogen accumulation and (ii) the involvement of Nrf2-TERT loop in maintaining oxidative defense responses in glioma cells.
Insights
This study reveals telomerase regulates cellular metabolism in glioma. Inhibiting human Telomerase reverse transcriptase (hTERT) impacts the pentose phosphate pathway and glycogen, affecting tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Glioma progression involves telomerase activation and altered metabolism.
- The interplay between telomerase and metabolic pathways in glioma remains underexplored.
Purpose of the Study:
- To investigate the connection between telomerase (hTERT) and metabolic dysregulation in glioma.
- To elucidate the role of hTERT in regulating key metabolic pathways and cellular responses.
Main Methods:
- Pharmacological inhibition of hTERT using Costunolide.
- siRNA-mediated knockdown and dominant-negative hTERT (DN-hTERT) expression.
- Analysis of reactive oxygen species (ROS), p53, Nrf2, pentose phosphate pathway (PPP) enzymes (G6PD, TKT), and glycogen metabolism.
- In vivo studies using a xenograft glioma mouse model.
- Analysis of glioblastoma multiforme (GBM) patient tumors with TERT promoter mutations.
Main Results:
- Costunolide induced glioma cell apoptosis via ROS-dependent mechanisms, increasing p53 and abrogating telomerase activity.
- hTERT inhibition decreased Nrf2 levels and key PPP enzymes (G6PD, TKT), leading to increased glycogen accumulation.
- An Nrf2-TERT feedback loop was identified, influencing oxidative defense.
- Costunolide reduced tumor burden in vivo, with decreased TKT activity and increased glycogen/senescence in tumors.
- GBM tumors with TERT mutations showed elevated Nrf2/TKT and reduced glycogen.
Conclusions:
- Telomerase (hTERT) plays a novel role in regulating the pentose phosphate pathway and glycogen accumulation in glioma.
- The Nrf2-TERT axis is crucial for maintaining oxidative defense in glioma cells.
- Targeting hTERT and its associated metabolic pathways presents a potential therapeutic strategy for glioma.
Related Concept Videos
Other Glycolytic Pathways
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
NF-kB-dependent Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades